North Carolina biotech inks $30M deal to expand its global pipeline

A biotechnology firm in Durham is betting millions on a potential treatment for hepatitis B.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 15, 2024 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news